Ovarian Cancer clinical trials
Showing 201–250 of 343 active trials. Describe your situation to see which ones you may be eligible for.
- A Study of LY4170156 in Participants With Selected Advanced Solid Tumors
- Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
- Administering Peripheral Blood Lymphocytes Transduced With a CD70-Binding Chimeric Antigen Receptor to People With CD70 Expressing Cancers
- A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
- A Study of NPX887 for Participants With Solid Tumors Known to Express B7-H7/HHLA2
- A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors
- IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
- A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
- Risk Reducing Salpingectomy With Delayed Oophorectomy as an Alternative to Risk- Reducing Salpingo-oophorectomy in High Risk-Women to Assess the Safety of Prevention - US Cohort Study
- A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer
- A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
- TUBectomy With Delayed Oophorectomy in High Risk Women to Assess the Safety of Prevention
- Gonadal Dysgenesis Tissue Cryopreservation for Fertility Preservation
- A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery
- CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
- Cryocompression to Reduce Chemotherapy-induced Peripheral Neuropathy in Gynecologic Cancer - COHORT 2
- A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE)
- Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
- A Nutrition & Exercise Prehabilitation Intervention on Inflammatory Biomarkers in AI Cancer Patients
- Ultrasound Microvessel Imaging for the Evaluation of Ovarian and Adnexal Lesions
- Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics
- Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
- Transvaginal Ultrasonography as a Screening Method for Ovarian Cancer
- Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302)
- Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.
- Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer
- A Study of Intra-operative Imaging in Women With Ovarian Cancer
- The Vanguard Study: Testing a New Way to Screen for Cancer
- Individual Response to Hyperthermic Intraperitoneal Chemotherapy (HIPEC) Treatment of Peritoneal Carcinomatosis From Peritoneal Mesothelioma or Atypical Mesothelial Proliferation or From Ovarian, Colorectal, or Appendiceal Histologies
- Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)
- 18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
- Safety of RAD301 in Healthy Human Volunteers and Patients With Pancreatic Cancer or Other Solid Tumors
- A Trial to Evaluate Safety, Tolerability, and Preliminary Efficacy of Misetionamide (GP-2250) as Monotherapy or in Combination With Gemcitabine
- Cognitive Impact of Neoadjuvant Chemotherapy for Ovarian Cancer
- UNTOLD Ovarian Cancer Unmet Needs Survey
- Healthy Volunteers Study
- Dysregulation of Whole-body Metabolism in Ovarian Cancer: A Longitudinal Study
- The SENTRY Study: Testing Whether Changes in Platelet RNA Enhance the Early Diagnosis of Ovarian Cancer
- Developing a Test of Uterine Lavage for the Detection of Ovarian Cancer
- Clinical Pre-screening Protocol for Ovarian Cancer
- Study of Tumor Tissue Samples From Patients Who Have Undergone Surgery for Advanced Stage III or Stage IV Ovarian Epithelial Cancer
- Study to Assess the Efficacy and Safety of Rina-S With or Without Bevacizumab Compared to Investigator's Choice of Platinum-based Chemotherapy With or Without Bevacizumab as Second-line Treatment in Participants With Recurrent Platinum-sensitive Ovarian Cancer
- Effect of NAC on Preventing Chemo-Related Cognitive Impairments in Ovarian Ca Pts Treated W/ PBT
- The Better, Harder, Faster, Stronger Study
- The EASE Study: Randomized Trial of a Novel Approach to Addressing Fear of Progression in Advanced Cancer
- WellSpan-THRIVE Cancer QOL Study
- Role of Mitochondrial Bioenergetics in Resilience for Gynecologic Cancer
- Laboratory Study of Cancer & Immune Cells in Ascites Fluid of Ovarian Cancer Patients to Test Alternative Therapies
- The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons
- Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.